RespireRx Pharmaceuticals Inc (fka RSPI)

[iggs]

Judy:

I have read the filings. I know the terms of the deal. I would like to know why they chose to raise as much as they did under the terms that were available via JMP. (There is more than one way to structure a financing.) Also, while I could understand that there were and still are concerns of a negative or protracted response from the FDA, I would like to know why $15MM was the magic number.

I suspect that $15MM was the right number because they want to have dry powder for inlicensing. Either that or they know something that we do not regarding the risks associated with the IND. Something doesn't feel right to me with the way things are being painted.

Sorry, I was not clear.

Iggs